PasqualeFNesticoMD

Echocardiography, Non-Invasive Cardiology, Preventive Cardiology

Cardiology Consultant of Philadelphia. Clinical Professor of Internal Medicine (Cardiology), Sidney Kimmel Medical College, Thomas Jefferson University.

Join to view full profile

Dr. Nestico is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nestico's full profile

Already have an account?

Office
1809 W Oregon Ave
Fl 1
Philadelphia, PA 19145
Phone+1 215-389-3890

Fax+1 215-551-0368

Summary

Dr. Pasquale Nestico is a cardiologist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Thomas Jefferson University Hospitals. He received his medical degree from Temple University School of Medicine and has been in practice 37 years. He specializes in adult cardiovascular disease.
He is a Clinical Professor of Medicine (Cardiology)
Sidney Kimmel Medical College,
Thomas Jefferson University.

Education & Training

Drexel University College of Medicine/Hahnemann University HospitalFellowship, Cardiovascular Disease, 1983 - 1985
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 1980 - 1983
Lewis Katz School of Medicine at Temple UniversityClass of 1980
Villanova UniversityB.S.E.E., Electrical Engineering, Graduated with High Honors, 1972
Villanova UniversityB.S., 1972

Certifications & Licensure

PA State Medical License 1981 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Outstanding Teacher of the Year Award in 1988, 1989 and 1990. St. Agnes Medical Center, 1988-1990
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Awarded the title of "Grande Ufficiale della Stella della Solidarieta'" by President of Italy, George Napolitano, 2009
Awarded the title of "Commendatore Ordine al Merito della Repubblica Italiana" President of Italy, George Napolitano, 2007
Achievement Army Medal for Meritorious Service, Consistent High Standards of Professionalism and Dedication to Duty with Great Credit to You US Army, 2005
Awarded the title of "Cavaliere della Stella della Solidarieta' Italiana" President of Italy Carlo Azeglio Ciampi, 2004
Awarded the title of Accademico A.E.R.E.C (Accademia Europea, per le relazioni economiche e culturali), Drexel University, 2003
Premio Calabria Centro D'Arte e Cultura "Bruzio" Gioia Tauro, Calabria, Italy, 2001
Citation for Dedicated Service as a Physician and a Civic Leader Senate of Pennsylvania, 2001
Citizenship Award for Significant Services as Founder and Past President Filitalia National, 2001
Time Feeling and Focus Award, Most Prestigious Award Honoring a Volunteer AHA, 1995
Heart of South Philly, Testimonial Dinner American Heart Association, Southeastern Pennsylvania Affiliate, 1995
Citation for Dedicated Service as a Physician and Civic Leader City Council of Philadelphia, 1995, 2001
Who's Who among Italian-Americans NIAF (National Italian-American Foundation), 1993
Steven's Who's Who in Health & Medicine 1991
Medal of Honor Philadelphia Exclusive, 1990
Honored by Commonwealth Lodge # 1949 OSIA (Order Sons of Italy in America), 1990
Man of the Year Award Greater Philadelphia Chapter UNICO National, 1990
"Oscar" Award of Merit, Senior Knight Commander of Goodness (Grande Ufficiale di Benevolenza) Italian-American Press, 1987
"Oscar" Award of Merit, Knight Commander of Goodness (Commendatore di Benevolenza) Italian-American Press, 1986
Premio Internazionale Calabria Mondo (Medicine) Campidoglio (City Hall), Rome, Italy, 1986
Man of the Year, for Academic Achievement and for Being a Humanitarian COSMI, 1985
Social Accomplishment and for Interest in Expanding the Italian Culture Marinai D'Italia Group G, 1984
Most Academic Resident Award Hahnemann University, 1983
Outstanding Resident of the Year St. Agnes Medical Center, 1983
Alpha Omega Alpha Temple Medical School, 1976
Ranked First in Class for Five Years in a Row, Winner of Two Scholarships Instituto Tecnico Industriale, 1962
Fellow (FACC) American College of Cardiology
Join now to see all

Publications & Presentations

PubMed

Left ventricular myocardial injury and syncope due to pulmonary embolism in a soldier: normal coronaries and novel pathologic electrocardiogram signs.
Pasquale F. Nestico, Dimitri C. Cassimatis, Fareed Sheikh, Michael Huber, Jonathan Davison
Military Medicine. 2008-07-01
Propafenone: a new antiarrhythmic drug.
Pasquale F. Nestico
American Family Physician. 1988-09-01
24 citations
New antiarrhythmic drugs.
Pasquale F. Nestico, Joel Morganroth, Leonard N. Horowitz
Drugs. 1988-03-01

Journal Articles

Left Ventricular injury and syncope due to Pulmonary Embolism in a soldier: Normal Coronaries and novel pathologic ECG signs
Nestico PF, Cassimatis DC, Sheikh F, Huber M, Davison J, Modlin R, Military Medicine, 1/1/2008
Cardiovascular outcomes using doxazosin vs chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: A report from the ALLHA...
Barzilay JI, Davis BR, Bettencourt J, Margolis KL, Goff DC, Black H, Habib G, Ellsworth A, Force RW, Wiegmann T, Ciocon JO, Basile JN, for the ALLHAT Collaborative Res..., J Clin Hypertens, 1/1/2004
The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease
Rahman M, Brown CD, Coresh J, Davis BR, Eckfeldt JH, Kopyt N, Levey AS, Nwachuku C, Pressel S, Reisin E, Walworth C, for the ALLHAT Collaborative Research Group, Arch Intern Med, 1/1/2004
Characteristics and lipid distribution of a large, high-risk, hypertensive population: The lipid-lowering component of the Antihypertensive and Lipid-Lowering Treatmen...
Papademetriou V, Piller LB, Ford CE, Gordon D, Hartney TJ, Geraci TS, Reison E, Sumner BM, Wong ND, Nwachuku C, Narayan P, Haywood LJ, Habib G, for the ALLHAT Collabor..., J Clin Hypertens, 1/1/2003
Diuretic versus Beta-blocker as first-step antihypertensive therapy Final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ...
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group, Hypertension, 1/1/2003
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive an...
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (Nestico PF), JAMA, 1/1/2002
Validation of heart failure events in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants assigned to doxazosin and c...
Piller LB, Davis BR, Cutler JA, Cushman WC, Wright JT, Jr, Williamson JD, Leenen FHH, Einhorn PT, Randall OS, Golden JS, Haywood LJ, for the ALLHAT Collaborative Resea..., Current Controlled Trials in Cardiovascular Medicine, 1/1/2002
Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or c...
Davis BR, Cutler JA, Furberg CD, Wright JT, Farber MA, Felicetta JV, Stokes JD, for the ALLHAT Collaborative Research Group (Nestico PF), Ann Intern Med, 1/1/2002
Baseline characteristics of the 42,448 high-risk hypertensives enrolled in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Grimm RH, Margolis KL, Papademetriou V, Cushman WC, Ford CE, Bettencourt J, Alderman MH, Basile JN, Black HR, DeQuattro V, Echfeldt J, Hawkins CM, Proschan M, for the ..., Hypertension, 1/1/2001
Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Barzilay JI, Jones CL, Davis BR, Basile JN, Goff DC, Ciocon JO, Sweeney ME, Randall OS, for the ALLHAT Collaborative Research Group (Nestico PF), Diabetes Care, 1/1/2001
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): Clinical center recruitment experience
Wright JT, Jr, Cushman WC, Davis BR, Barzilay J, Colon P, Egan D, Lucente T, Nwachuku C, Pressel S, Leenen FHH, Frolkis J, Letterer R, Walsh S, Tobin JN, Deger GE, for..., Controlled Clinical Trials, 1/1/2001
Operational aspects of terminating the doxazosin arm of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Pressel SL, Davis BR, Wright JT, Geraci TS, Kingry C, Ford CE, Piller LB, Bettencourt J, Kimmel B, Lush C, Parks H, Simpson LM, Nwachuku C, Furberg CD, for the ALLHAT ..., Controlled Clinical Trials, 1/1/2001
Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Pressel S, Davis BR, Louis GT, Whelton P, Adrogue H, Egan D, Farber M, Payne G, Probstfield J, Ward H, for the ALLHAT Research Group (Nestico PF), Controlled Clinical Trials, 1/1/2001
ALLHAT and calcium channel blockers
Proschan M, Davis B, Cutler J, Ford C, Furberg, C, Grimm R, Oparil S, for the ALLHAT Research Group, Am J Hypertension, 1/1/1997
Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Atta...
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (Nestico PF), JAMA, 1/1/1996
Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to prevent heart attack trial (ALLHAT)
Davis BR, for the ALLHAT Research Group (Nestico PF), American J. Hypertension, 1/1/1996
Ventricular Disarrhythmias: Diagnosis and treatment
Nestico PF, Hospital Medicine, 1/1/1990
Tricuspid regurgitation
Nestico PF, Morganroth J, McGinn C, Primary Cardiology, 1/1/1989
Flail mitral valve Manifestations and natural history
Nestico PF, DePace NL, Primary Cardiology, 1/1/1989
New Antiarrhythmic drugs
Nestico PF, Morganroth J, Horowitz LN, DRUG, 1/1/1988
Treatment of resistant Ventricular Tachycardia with Encainide Hydrochloride
The Encainide-Ventricular Tachycardia Study Group (Nestico PF), Am J Cardiol, 1/1/1988
Propafanone: A new Antiarrhythmic Drug
Nestico PF, Am Family Physician, 1/1/1988
Relative prognostic value of rest thallium-201 imaging, radionuclide ventricullography and 24 hour Ambulatory Electrocardiographic monitoring after acute myocardial in...
Hakki AH, Nestico PF, Heo J, et al, J Am Col Cardiol, 1/1/1987
Antiarrhythmic agents for chronic ventricular arrhythmias Current Concepts
Nestico PF, Morganroth J, Comprehensive Therapy, 1/1/1987
Effects of beta-blockade on systolic and diastolic left ventricular function at rest and during exercise in patients with chronic stable angina pectoris
Iskandrian AS, Nestico PF, Hakki AH, et al, Am Heart J, 1/1/1987
Join now to see all

Books/Book Chapters

Modern Coronary Care
Chapter: Ambulatory monitoring after myocardial infarction.
Page 653 - 655Nestico PF, Morganroth JEditors: Gary S. Francis and Joseph S. Alpert.Little, Brown and Company1990
Emergency in Cardiology
Chapter: Sudden Cardiac Death.
Page 198 - 206Nestico PF, Morganroth JEditors: Dereck J. Rowlands.John Wright and Sons Ltd., Hertfordshire, England1989
Cardiovascular Clinics
Chapter: Congestive Heart Failure and ventricular arrhythmias.
Nestico PF, Morganroth JEditors: Albert Brest, Jefferson.1988
The pathophysiology and pharmacotherapy of myocardial infarction.
Chapter: The pharmacology of antiarrhythmic drugs.
Page 241 - 268Nestico PF, Morganroth JEditors: N. El-Sherif and CV Ramana Reddy.Academy Press, Inc., New York, NY1986
Cardiology
Chapter: Ambulatory Holter Electrocardiography: Technology, Clinical Applications and Limitations.
Morganroth J, Nestico PFEditors: William W. Parmley and Kanu Chatterjee.J.B. Lippincott Company, Philadelphia, PA1986
Sudden Cardiac Death
Chapter: Experimental antiarrhythmic drugs.
Page 191 - 247Morganroth J, Nestico PF, Horowitz LNEditors: J. Morganroth and LN Horowitz.Grune & Stratton, Inc., Orlando, FL1985
Join now to see all

Abstracts/Posters

Blood pressure control in Hispanics in the Antihypertensive and Lipid-Lowering Treatment to Prehvent Heart Attack Trial (ALLHAT).
Ford CE, Margolis KL, Piller L, Cushman WC, Wright JT, Colon PJ, for the ALLHAT Collaborative Research Group, 15th Scientific Meeting of the Inter-American Society of Hypertension, San Antonio, TX, 1/27/2003
Cardiovascular Disease (CVD) outcomes in hypertensive patientswith impaired renal function.
Rahman M, Cutler J, Davis B, Pressel S, Whelton P, for the ALLHAT Collaborative Research Group, National Kidney Foundations Clinical Meetings, Dallas, TX, 1/2/2003
Renal outcomes in hypertensive patients with impaired renal function.
Rahman M, Cutler J, Davis B, Pressel S, Whelton P, for the ALLHAT Collaborative Research Group, National Kidney Foundations Clinical Meetings, Dallas, TX, 1/2/2003
Review of heart failure events in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): ALLHAT Heart Failure Validation Study.
Einhorn P, Davis B, Piller L, deLeon B, Simpson L, Kostis J, Levy D, Massie B, Nwachuku C, Black H, Cushman W, for the ALLHAT Collaborative Research Group, Circulattihon; 76th Annual Scientific Sessions of the American Heart Association, Orlando, FL, 1/1/2003
Baseline Characteristics of ALLHAT participants with impaired renal function; association with cardiovascular disease.
Rahman M, Brown C, Coresh J, Eckfeldt J, Jelley M, Kopyt N, Levey A, Pressel S, Reisin E, Walworth C, Davis B and the ALLHAT Collaborative Research Group, Am J Hytpertension; 17th Annual Meeting of the American Society of Hypertension, New York, NY, 1/1/2002
Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: Preliminary restults from ALLHAT.
The ALLHAT Collaborative Research Group, 49th Annual Scientific Session of the American College of Cardiology, Late-breaking clinical trials in Interventional Cardiology (#72), Anaheim, CA, 1/15/2000
Clinical center recruitment experience in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Davis BR, Pressel S, Wright J, Cushman W, Barzilay J, Colon P, Egan D, Lucente T, Nwachuku C, Leenen F, Frolkis J, Letterer R, Walsh S, Tobin J, Deger G, for the ALLHA..., Control led Clinical Trials; 21st Annual Meeting of the Society for Clinical Trials, Toronto, Ontario, Canada, 1/1/2000
Cardiovascular disease rates in Hispanic and Caribbean hypertensives receiving doxazosin and chlorthalidone in the ALLHAT.
Colon PJ, Wright JT, Ford CE, Cuttler JA, for the ALLHAT Collaborative Research Group, Ethnicity and Disease; Joint Meteting of the International Society for Hypertension in Blacks and the 15th Annual Interdisciplinary Conference on Hypertension and Related Risk Factors in Ethnic Populations, Las Croabas, Puerto Rico, 1/1/2000
ALLHAT Adherence Survival Kit.
Lusk CM, Egan D, Carroll L, Kingry C, Johnson JM, Sullivan S, Probstfield J for the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial, Controlled Clinical Trials; 20th Annual Meeting of the Society for Clinical Trials, Anaheim, CA, 1/1/1999
Racial differences in blood pressure control in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Margolis KL, Cushman WC, Wright JT, Grimm RH, Ford CE, Cutler JA for the ALLHAT Research Group, J General Internal medicine; 22 nd Annual Meeting of the Society for General Internal Medicine, San Francisco, CA, 1/1/1999
Atrial fibrillation in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) clinical trial at baseline.
Haywood LJ, Crow R, Ford C, for the ALLHAT Research Group, Ethnicity and Disease; 14th International Interdisciplinary Conference on Hypertension in Blacks, Toronto, Ontario, Canada, 1/1/1999
ALLHAT: The largest clinical trial in hypertension ever undertaken.
Davis BR, Hawkins CM, Cutler, JA, Payne G, Ford CE, Pressel S, Gordon D, Nwachuku C, Wright J, Cushman W, Grimm R for the ALLHAT Research Group, 6th International Symposium on Hypertension in the Community: Screening, Investigation, and Therapy, Geneva, Switzerland, 1/8/1998
Blood pressure control in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Cushman WC, Black HR, Probstfield JL, Holland JJ, Hamilton BP, Margolis K, Nwachuku CE, Payne GH, Ford CE for the ALLHAT Research Group, Am J Hypertension; 13th Scientific Meeting of the American Society of Hypertension, New York, NY, 1/1/1998
Visit (Vad) and Medication (Mad) adherence in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): Effect of age and other factors.
Nwachuku CE, Probstfield JL, Ford CE, Payne GH, Grimm RH for the ALLHAT Research Group, Am J Hypertension; 13th Scientific Meeting of the American Society of Hypertension, New York, NY, 1/1/1998
The antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT); Design, recruitmhent experience and baseline characteristics.
Papademetriou V, Grimm KH, Jr, for the ALLHAT Research Group, 4th International Symposium on Multiple Risk Factors in Cardiovascular Disease, Washington, DC, 1/23/1997
Characteristics of the diabetic cohort in the ALLHAT study.
Barzilay J, Jordan J, Grimm R, Davis B, Oparil S, and the ALLHAT investigators, Hypertension; 12th Scientific Meeting of the Inter-American Society of Hypertension, San Francisco, CA, 1/1/1997
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): Recruitment update and baselinetdata.
Wright JT, Jr, Cutler JA, Davis BR, Cushman WC, Pressel S, for the ALLHAT Research Group, 11th International Interdisciplinary Conference on Hypertension in Blacks, New Orleans, LA, 1/14/1996
Statistical issues in a large, simple trial of antihypertensive and lipid-lowering treatments.
Davis BR, Proschan M, Ford CE, for the ALLHAT Research Group, American Statistical Association Meeting, Chicago, IL, 1/4/1996
Patient recruitment experience in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Whelton P, Cutler J, Davis B, Grimm R, Pressel S, Probstfield J, Ward H, for the ALLHAT Research Group, 16t h Scientific Meeting of the International Society of Hypertension Conference abstract monograph;, Glasgow, United Kingdom, 1/1/1996
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): update on recruitment and baseline characteristic.
Grimm RH, Jr, Davis B, Whelton P, Pressel S, for the ALLHAT Research Group, Am J Hypertension; 11th Scientific Meeting of the American Society of Hypertension, New York, NY, 1/1/1996
Statistical design considerations for a large, simple trial of antihypertensive and lipid lowering treatments.
Davis B, Proschan M, Ford CE, for the ALLHAT Research Group, International Biometric Conference, Amsterdam, Netherlands, 1/1/1996
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT): Design and early baseline results.
Grimm RH, Jr, for the ALLHAT Research Group, 11th Asian-Pacific Congress of Cardiology, Bali, Indonesia, 1/17/1995
Selection of Clinical Sites for the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Pressel S, Egan D, Ford C, Walsh S, Miertehin N, on behalf of the ALLHAT Research Group, Controlled Clinical Trials; 16th Annual Meeting of the Society for Clinical Trials, Seattle, WA, 1/1/1995
Recruitment success by type of site in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Vanguard.
Egan D, Pressel S, Davis B, on behalf of the ALLHAT Research Group, Controlled Clinical Trials; 16th Annual Meeting of the Society for Clinical Trials, Seattle, WA, 1/1/1995
The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: Design features.
Davis B, for the ALLHAT Research Group, Controlled Clinical Trials; 16th Annual Meeting of the Society for Clinical Trials, Seattle, WA, 1/1/1995
Join now to see all

Lectures

Improving Blood Pressure Treatment in the community: How the JNC 7 Recommendation and ALLHAT results relate to your practice.
Methodist Hospital, Philadelphia, PA - 1/3/2006
Aortic Stenosis-An Important Disease
Methodist Hospital, Philadelphia, PA - 1/15/2000
Hypertension and Angiotensin II Receptor Antagonist (sponsored by Merck)
Philippino-AM Comm. Center, Philadelphia, PA - 1/26/1998
Hypercholesterolemia-New Directions
Methodist Hospital, Philadelphia, PA - 1/3/1997
Atherosclerosis and its Sequelae
J.C. Penny, Philadelphia, PA - 1/16/1994
Risk Factors for Cardiovascular Disease
J.C. Penny, Philadelphia, PA - 1/30/1993
Non-Invasive Assessment of Ventricular Arrhythmia
Franklin Square Hospital, Philadelphia, PA - 1/9/1992
Therapy for Ventricular Arrhythmia Revisited
Methodist Hospital, Philadelphia, PA - 1/2/1992
Diagnosing Heart Problems.
St. Agnes Medical Center, Philadelphia, PA - 1/11/1991
Chest Pain.
Palumbo's Restaurant, Philadelphia, PA - 1/27/1990
Silent Ischemia
Venice Plaza, Philadelphia, PA - 1/17/1990
Ventricular Arrhythmias
Hilton Hotel, Mount Laurel, NJ - 1/17/1990
Congestive Heart Failure
St. Agnes Medical Center, Philadelphia, PA - 1/5/1989
Risk factors for Coronary Artery Disease.
St. Agnes Medical Center, Philadelphia, PA - 1/25/1988
Hypertension-New Modalities
St. Agnes Medical Center, Philadelphia, PA - 1/20/1988
Arrhythmias
St. Agnes Medical Center, Philadelphia, PA - 1/8/1988
Making Sense of the New Antiarrhythmics
St. Joseph Medical Center, Hazelton, PA - 1/8/1987
Dysrhythmia Management
St. Agnes Medical Center, Philadelphia, PA - 1/23/1985
Be good to your heart.
St. Agnes Medical Center, Philadelphia, PA - 1/19/1985
The Heart and How It Works
St. Agnes Medical Center, Philadelphia, PA - 1/19/1985
Physical Auscultation.
St. Agnes Medical Center, Philadelphia, PA - 1/9/1985
Successful Case of PTCA.
Hahnemann University - 1/4/1985
Superventricular Tachycardia.
Hahnemann University - 1/4/1985
Join now to see all